News on China's scientific and technological development.

dingyibvs

Senior Member

TCL Surpass Samsung in Premium Market​


TCL captured 23% of the 80-inch-and-above TV market in Q3 2024, maintaining its lead over Samsung for two consecutive quarters. Samsung’s market share in this segment dropped from 26% in Q3 2023 to 19% in Q3 2024, while Hisense has narrowed the gap with Samsung to just 1.65 percentage points.

Chinese TVs are no longer perceived as cheap, low-quality options. With advanced features such as AI-powered processors and ultra-large screens, Chinese brands now rival South Korean models in performance.

Please, Log in or Register to view URLs content!
I just bought a 98 inch TCL TV, it's arriving this weekend. It's kinda amazing how things have changed. When I was a kid in China I remember lusting over the electronics of the west, how huge their TVs were when all we had available were tiny ones. Now, living in the US, the best TCL TVs we get are actually last year's models, and they still beat Samsung's best at a fraction of the price. Samsung uses TCL's CSOT panels BTW, so it makes no sense to pay so much more for a Samsung.
 

sunnymaxi

Major
Registered Member
Honestly, i have lost count.

Another one.

China-born biologist Wang Cunyu returns from decades in US to head advanced institute​


Renowned biologist Wang Cunyu has returned to China after more than three decades in the United States, joining Peking University as the head of its Institute of Advanced Clinical Medicine (IACM). Wang plans to lead the institute in addressing clinical needs, leveraging cross-disciplinary advantages, and bridging the gap between basic research and clinical applications. His vision is to establish the institute as a global leader in medical innovation..

Please, Log in or Register to view URLs content!
 

sunnymaxi

Major
Registered Member
Chinese company Juncell Opens World’s Largest TIL Facility in Shanghai

Juncell Therapeutics has opened the world’s largest tumor-infiltrating lymphocyte facility in Shanghai and plans to produce and market its innovative GC101 TIL therapy for advanced melanoma by 2026.

Covering over 16,000 square meters, the facility includes production, quality control, data management, and operational centers, the Shanghai-based company announced yesterday. It will be able to turn out products for between 6,000 and 10,000 patients per year.

The new base will advance TIL product development and accelerate the industrial application of disruptive innovative technologies, Juncell said. The drugmaker’s first such product, GC101, will be produced there, an employee stated.

Please, Log in or Register to view URLs content!
 
Top